As of 2024-12-15, the Relative Valuation of Design Therapeutics Inc (DSGN) is (15.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.60 USD, the upside of Design Therapeutics Inc based on Relative Valuation is -373.5%.
The range of the Relative Valuation is (15.86) - (16.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 24.1x | 17.3x |
| Forward P/E multiples | 18.8x - 19.2x | 19.0x |
| Fair Price | (15.86) - (16.17) | (15.32) |
| Upside | -383.3% - -388.7% | -373.5% |
| Date | P/E |
| 2024-11-25 | -6.66 |
| 2024-11-22 | -6.66 |
| 2024-11-21 | -6.60 |
| 2024-11-20 | -6.49 |
| 2024-11-19 | -6.49 |
| 2024-11-18 | -6.83 |
| 2024-11-15 | -6.87 |
| 2024-11-14 | -7.13 |
| 2024-11-13 | -8.89 |
| 2024-11-12 | -8.19 |
| 2024-11-11 | -7.83 |
| 2024-11-08 | -6.91 |
| 2024-11-07 | -6.86 |
| 2024-11-06 | -7.04 |
| 2024-11-05 | -6.59 |
| 2024-11-04 | -6.30 |
| 2024-11-01 | -6.16 |
| 2024-10-31 | -6.21 |
| 2024-10-30 | -6.60 |
| 2024-10-29 | -6.41 |
| 2024-10-28 | -6.55 |
| 2024-10-25 | -6.45 |
| 2024-10-24 | -6.34 |
| 2024-10-23 | -6.71 |
| 2024-10-22 | -6.72 |
| 2024-10-21 | -6.64 |
| 2024-10-18 | -6.63 |
| 2024-10-17 | -7.13 |
| 2024-10-16 | -6.70 |
| 2024-10-15 | -6.39 |
| 2024-10-14 | -6.10 |
| 2024-10-11 | -5.93 |
| 2024-10-10 | -5.53 |
| 2024-10-09 | -5.55 |
| 2024-10-08 | -5.83 |
| 2024-10-07 | -5.40 |
| 2024-10-04 | -5.93 |
| 2024-10-03 | -5.59 |
| 2024-10-02 | -5.89 |
| 2024-10-01 | -6.10 |
| 2024-09-30 | -6.38 |
| 2024-09-27 | -6.32 |
| 2024-09-26 | -6.42 |
| 2024-09-25 | -6.38 |
| 2024-09-24 | -6.41 |
| 2024-09-23 | -6.34 |
| 2024-09-20 | -6.97 |
| 2024-09-19 | -6.94 |
| 2024-09-18 | -6.68 |
| 2024-09-17 | -6.84 |